Kini saatnya Bio Farma melakukan perubahan kearah yang lebih baik menuju inovasi Bioteknologi yang berdaya saing global dengan menerapkan strategi perusahaan tahun 2017 - 2021.
Corporate Plan & Business Development Strategy
Business development and corporate planning strategy was aimed tointensify R&D activities to improve our product portfolio.
Human Capital & Innovation Strategy
Human capital and innovation strategy was aimed to develop various levels of the company, from process, product, to research to encourage tangible internal developments for our external shareholders.
Manufacture & Supply Chain Strategy
The main aim of the strategy was aimed to improve capacity by procuring production machinery, particularly for the fill & finish process. By taking advantage of information technology and ERP systems, we were able to improve our supply chain process to ensure the readiness of raw materials and thus ensure that vaccine production was on target and able to meet national and global demands.
Investment & Asset Management Strategy
Investment and asset management strategy was aimed to improve capacity and diversify our product portfolio by investing in new production infrastructure and land. Land for facilities was procured with regard to the environment.
Financial Support Strategy
Our financial strategy was supported by an integrated IT system at every level of the company.
Kini saatnya Bio Farma melakukan perubahan ke arah yang lebih baik menuju inovasi bioteknologi berdaya saing global dengan menyusun strategi 2017 - 2021